US Bancorp’s Biofrontera BFRIW Stock Holding History

US Bancorp’s Portfolio BFRIW Stock Details BFRIW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27	Hold	1,000	–	–	﹤0.01%	4145
2026 Q1	$38	Hold	1,000	–	–	﹤0.01%	4142
2025 Q4	$90	Hold	1,000	–	–	﹤0.01%	4002
2025 Q3	$97	Hold	1,000	–	–	﹤0.01%	3965
2025 Q2	$105	Hold	1,000	–	–	﹤0.01%	4109
2025 Q1	$61	Hold	1,000	–	–	﹤0.01%	4149
2024 Q4	$61	Hold	1,000	–	–	﹤0.01%	4118
2024 Q3	$23	Hold	1,000	–	–	﹤0.01%	4056
2024 Q2	$35	Hold	1,000	–	–	﹤0.01%	3946
2024 Q1	$68	Hold	1,000	–	–	﹤0.01%	3930
2023 Q4	$10	Hold	1,000	–	–	﹤0.01%	3951
2023 Q3	$30	Hold	1,000	–	–	﹤0.01%	3958
2023 Q2	$110	Hold	1,000	–	–	﹤0.01%	3939
2023 Q1	$245	Buy	+1,000	New	+$250	﹤0.01%	4008

Other funds holding BFRIW

Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

US Bancorp's BFRIW Position: Q2 2026 in Review

US Bancorp held its Biofrontera (BFRIW) position steady in Q2 2026 at 1,000 shares worth $27. The position accounts for ﹤0.01% of the portfolio, ranked #4145.

US Bancorp first reported a position in BFRIW in Q1 2023 and has held it in 14 quarters since. The position peaked at $245 in Q1 2023. 5 funds tracked by Wall St. Rank hold BFRIW as of Q2 2026.

US Bancorp held 1,000 shares of Biofrontera worth $27 as of Q2 2026.
US Bancorp left its Biofrontera share count unchanged in Q2 2026.
Biofrontera made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #4145 holding.
US Bancorp first reported a position in Biofrontera in Q1 2023 and has held it in 14 quarters since.
US Bancorp's Biofrontera position peaked at $245 in Q1 2023.
5 funds tracked by Wall St. Rank held Biofrontera as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.